# Study of CM310 in Children Subjects With Moderate-to-severe Atopic Dermatis

> **NCT06162507** · PHASE1,PHASE2 · COMPLETED · sponsor: **Keymed Biosciences Co.Ltd** · enrollment: 24 (actual)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **BIOLOGICAL:** CM310

## Key facts

- **NCT ID:** NCT06162507
- **Lead sponsor:** Keymed Biosciences Co.Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-12-22
- **Primary completion:** 2024-07-04
- **Final completion:** 2024-07-04
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2024-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06162507

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06162507, "Study of CM310 in Children Subjects With Moderate-to-severe Atopic Dermatis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06162507. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*